post relapse bone sarcoma
Showing 1 - 25 of >10,000
Osteosarcoma, Ewing Sarcoma Trial in Bologna (Metformin Hydrochloride)
Recruiting
- Osteosarcoma
- Ewing Sarcoma
- Metformin Hydrochloride
-
Bologna, ItalyChemotherapy Div, Istituto Ortopedico Rizzoli
Mar 28, 2021
Blood Loss, Surgical Trial in Lahore (Tranexamic acid injection, normal saline)
Recruiting
- Blood Loss, Surgical
- Tranexamic acid injection
- normal saline
-
Lahore, Punjab, PakistanShaukat Khanum Memorial Cancer Hospital & Research Center
Jun 22, 2022
Bone Sarcoma, Osteosarcoma Trial in France (Treatment by regorafenib and best supportive care, Treatment by and best supportive
Recruiting
- Bone Sarcoma
- Osteosarcoma
- Treatment by regorafenib and best supportive care
- Treatment by placebo and best supportive care
-
Besançon, France
- +13 more
May 12, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CPI 613
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
May 10, 2023
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C
Not yet recruiting
- Acute Myeloid Leukemia
- +4 more
- (no location specified)
Nov 1, 2023
Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body
Recruiting
- Sarcoma
- +2 more
- Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)
Not yet recruiting
- Osteogenic Sarcoma Recurrent
-
Hackensack, New Jersey
- +1 more
Feb 3, 2023
Radiation Effects on Bone
Enrolling by invitation
- Soft Tissue Sarcoma Adult
- Control Group
- +3 more
-
Syracuse, New YorkSUNY Upstate Medical University
Oct 31, 2022
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)
Active, not recruiting
- Ewing Sarcoma
- +12 more
- Vigil
- +2 more
-
Little Rock, Arkansas
- +16 more
Feb 9, 2022
Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)
Not yet recruiting
- Sarcoma, Ewing
- Rhabdomyosarcoma
- PEN-866
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
Refractory and/or Relapsed Metastatic Solid Tumors Trial in United States (Cyclophosphamide, Fludarabine, low dose total body
Recruiting
- Refractory and/or Relapsed Metastatic Solid Tumors
- Cyclophosphamide
- +4 more
-
Saint Petersburg, Florida
- +4 more
Oct 29, 2021
Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and
Completed
- Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
-
Roma, ItalyServizio E Dh Di Ematologia
Feb 23, 2023
Sarcoma, Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate)
Recruiting
- Sarcoma
- +4 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Feb 9, 2022
Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma
Recruiting
- Pediatric Soft Tissue Sarcoma
- detection and monitoring of cirulating tumor DNA
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 20, 2023
Soft Tissue Sarcoma, Desmoid; Abdominal Trial in Oxford (High Intensity Focused Ultrasound Ablation, Tumour Biopsy and Venous
Recruiting
- Soft Tissue Sarcoma
- Desmoid; Abdominal
- High Intensity Focused Ultrasound Ablation
- Tumour Biopsy and Venous Blood Tests
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Jan 16, 2023
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023
Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Recruiting
- Sarcoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
-
Beijing, ChinaPeking University People's Hospital
Nov 6, 2023
Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma Trial in Worldwide (Quality assessment)
Unknown status
- Soft-tissue Sarcoma
- +2 more
- Quality assessment
-
Buenos Aires, Argentina
- +8 more
Feb 9, 2021
Sarcoma Trial in Toulouse (Surgical prehabilitation program.)
Recruiting
- Sarcoma
- Surgical prehabilitation program.
-
Toulouse, FranceInstitut Universitaire du Cancer de Toulouse - Oncopole
Mar 30, 2022
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022